Health Care & Life Sciences » Biotechnology | Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW557.49
Market Cap
KRW340.08 B
Shares Outstanding
20.8 M
Public Float
15.73 M

Profile

Address
17th Floor, Shinan Building
Seoul SL 06179
Korea, Republic Of
Employees -
Website http://www.kangstem.com
Updated 09/14/2018
KangStem Biotech Co., Ltd. develops and commercializes stem cell therapies. Its therapies include next generation and gene-loaded stem cell. In addition, it also provides contract research and manufacturing services and drug screening services.

Financials

View All

Kyung-Sun Kang
Chairman
Tae-Hwa Lee
Chief Executive Officer & Director